Effect of early plasmapheresis and immunosuppressive therapy on natural history of anti-glomerular basement membrane glomerulonephritis: report of a 22-month follow-up
- PMID: 426585
Effect of early plasmapheresis and immunosuppressive therapy on natural history of anti-glomerular basement membrane glomerulonephritis: report of a 22-month follow-up
Abstract
A patient with anti-glomerular basement membrane (GBM)-mediated necrotizing and proliferative glomerulonephritis with crescents was treated with plasmapheresis, cyclophosphamide, and steroids. Treatment resulted in decreased circulating anti-GBM antibody and prompt improvement of renal function that remained stable for 15 months after all treatment was discontinued. Renal biopsies were performed initially, at seven and 17 months. Immunofluorescent examination showed that anti-GBM antibody continued to be present on GBMs although light and electron microscopic findings demonstrated a transformation to a form of sclerosing glomerulonephritis. To our knowledge, this patient's course is the first demonstration that early treatment with plasmapheresis and immunosuppressions may transform the histologic findings in anti-GBM-induced rapidly progressive glomerulonephritis, thereby altering the natural history of this disease.
Similar articles
-
Recovery from rapidly progressive glomerulonephritis. Improvement after plasmapheresis and immunosuppression.Arch Intern Med. 1981 Feb;141(2):175-80. Arch Intern Med. 1981. PMID: 7006545
-
Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.Am J Kidney Dis. 2002 Jan;39(1):28-35. doi: 10.1053/ajkd.2002.29874. Am J Kidney Dis. 2002. PMID: 11774098
-
[Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].Ann Med Interne (Paris). 1990;141(5):409-15. Ann Med Interne (Paris). 1990. PMID: 2256583 Review. French.
-
Rapid progressive glomerulonephritis: relapse after prolonged remission.Arch Intern Med. 1981 Jun;141(7):852-4. Arch Intern Med. 1981. PMID: 7235804
-
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.Am J Kidney Dis. 2005 Aug;46(2):253-62. doi: 10.1053/j.ajkd.2005.05.003. Am J Kidney Dis. 2005. PMID: 16112043 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources